Skip to Main Content

Paper Details

Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
ESMO Open
0
2022
Author NameAffiliation
Cora N SternbergEnglander Institute for Precision Medicine, Sandra and Edward Meyer Cancer Center
Maha HussainLurie Cancer Center, Northwestern University
Fred SaadCentre Hospitalier de l'Universite de Montreal (CHUM)
  • 1 - 3

Datasets

Release 1.2